US Patent Issued to Larimar Therapeutics on Sept. 9 for "Methods for quantifying frataxin activity" (Pennsylvania Inventor)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,411,145, issued on Sept. 9, was assigned to Larimar Therapeutics Inc. (Bala Cynwyd, Pa.).

"Methods for quantifying frataxin activity" was invented by Joan David Bettoun (Elkins Park, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods, compositions and kits for measuring activity of a frataxin (FXN) protein, e.g., an FXN fusion protein. The present invention also provides methods for identifying compounds capable of modulating activity of an FXN protein, e.g., an FXN fusion protein."

The patent was filed on April 17, 2024, under Application No. 18/637,707.

*For further information, including images, charts and t...